The facility complies with GMP/GCTP standards and has been used as a demonstration facility for gene therapy projects. Due to a recent permission by the Ministry of Health, Labor and Welfare, it ican also be used for clinical cell processing services such as stem cells and transgenic cells. Since October 2014, Takara Bio operates a gene/cell processing center in Kusatsu City, Shiga Prefecture in compliance with GMP/GCTP standards, and is engaged in CDMO projects. The LIC plant will help Takara Bio to further expand its CDMO business for regenerative medicine.

Takara Bio news release, January 9, 2018